Genomic Valley

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE574D01010
  • NSEID:
  • BSEID: 539206
INR
23.40
0.95 (4.23%)
BSENSE

Dec 22

BSE+NSE Vol: 606

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 411.25% vs -93.94% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 2,848.89% vs -98.31% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -8.38% vs -93.62% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 2,245.53% vs -97.66% in Mar 2024

Compare Profit and Loss Results of Genomic Valley
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
0.00
2.00
-2.00
-100.00%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
0.00
2.00
-2.00
-100.00%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
1.00
-1.00
-100.00%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
0.00
0.00
0.00
0%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
0.00
2.00
-2.00
-100.00%
Operating Profit (PBDIT) excl Other Income
0.00
0.00
0.00
0%
Other Income
0.00
0.00
0.00
0%
Operating Profit (PBDIT)
0.00
0.00
0.00
0%
Interest
0.00
0.00
0.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
0.00
0.00
0.00
0%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
0.00
0.00
0.00
0%
Provision for Tax
0.00
0.00
0.00
0%
Profit After Tax
0.00
0.00
0.00
0%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.17
0.16
1.01
631.25%
Profit And Loss - Net Sales
Net Sales 0.84 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 411.25% vs -93.94% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.44 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2,848.89% vs -98.31% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -8.38% vs -93.62% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 0.36 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 2,245.53% vs -97.66% in Mar 2024